{"filing":{"accession_number":"0001628280-26-043419","cik":"0001417663","ticker":"SNWV","company_name":"SANUWAVE Health, Inc.","form":"8-K","filing_date":"2026-06-16","report_date":null,"primary_document":"snwv-20260616.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026043419/snwv-20260616.htm"},"events":[{"id":11212,"run_id":9832,"accession_number":"0001628280-26-043419","anchor_item_number":"7.01","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The filing discloses a press release announcing \"updated guidance for the quarter ended June 30, 2026,\" which constitutes forward-looking financial information material to investors' assessment of the company's expected performance. While technically disclosed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is guidance disclosure—a form of earnings-related announcement that would affect a reasonable investor's view of the registrant's financial trajectory.","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-06-16","form":"8-K","submitted_at":null,"items":[{"id":7748,"accession_number":"0001628280-26-043419","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a press release announcing \"updated guidance for the quarter ended June 30, 2026,\" which constitutes forward-looking financial information material to investors' assessment of the company's expected performance. While technically disclosed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is guidance disclosure—a form of earnings-related announcement that would affect a reasonable investor's view of the registrant's financial trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T12:08:05.899020+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7748,"accession_number":"0001628280-26-043419","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a press release announcing \"updated guidance for the quarter ended June 30, 2026,\" which constitutes forward-looking financial information material to investors' assessment of the company's expected performance. While technically disclosed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is guidance disclosure—a form of earnings-related announcement that would affect a reasonable investor's view of the registrant's financial trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T12:08:05.899020+00:00","company_name":"SANUWAVE Health, Inc.","ticker":"SNWV","filing_date":"2026-06-16"}]}